SCHEMBL4755191

SCHEMBL4755191

CCOCc1nc2cnc3ccccc3c2n1N=CCCNC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 5/20 0.39
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 3/20 0.37
PLA2G1B P04054 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
TLR8 Q9NR97 5/20 0.37
NUDT1 P36639 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALPL P05186 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 3/20 0.34
ALPI P09923 1/20 0.34
GAA P10253 1/20 0.34
ALPG P10696 1/20 0.34
TSHR P16473 2/20 0.34
HTT P42858 2/20 0.34
MAPT P10636 2/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755190 1.00 TLR7 (0.39) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL5810799 0.81 TLR8 (0.39) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL5810795 0.81 TLR8 (0.39) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL1950513 0.80 TLR7 (0.45) TLR7KMT2AALDH1A1MEN1TLR8
SCHEMBL4756665 0.80 TLR7 (0.37) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL4756669 0.80 TLR7 (0.37) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL5447365 0.80 ALDH1A1 (0.46) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL4790061 0.80 ALDH1A1 (0.46) TLR7KMT2AALDH1A1MEN1PLA2G1B
SCHEMBL9940820 0.79 TLR7 (0.45) TLR7KMT2AMEN1TLR8NUDT1
SCHEMBL4756426 0.79 TLR7 (0.41) TLR7KMT2AALDH1A1MEN1TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1605943-A4 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES CO (US) 2008-01-16 EP disclosed
US-7163947-B2 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-01-16 US disclosed
EP-1605943-A2 1-AMINO 1H-IMIDAZOQUINOLINES 3M Innovative Properties Company (US) 2005-12-21 EP disclosed
US-20050054640-A1 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2005-03-10 US disclosed
WO-2004080398-A2 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-09-23 WO disclosed
US-20040176367-A1 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176367-A1 1-Amino 1H-imidazoquinolines IL2, IFNG, IL4I1 TLR7 146/4885KMT2A 2385/4885ALDH1A1 405/4885
US-20050054640-A1 1-Amino 1H-imidazoquinolines IL2, IFNG, IL4I1 TLR7 146/4885KMT2A 2385/4885ALDH1A1 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.